AzTrials
AzTrials

Negative Pressure VentilationNCT06572072

Effects of Negative Pressure Ventilation on Right Ventricular Function in Cardiological Patients

An observational study of Negative Pressure Ventilation and Right Ventricular Dysfunction, run by Karlsburg Hospital at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients receives induction of general anesthesia for interventional tricuspidal clipping and standard monitoring for this procedure including arterial and central venous line and transesophageal ultrasound. A cuirass for extrathoracal negative pressure ventilation is placed onto the chest but not switched on. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Negative Pressure Ventilation
Type of treatment
Medical device
How many people
30 participants
Where
1 siteGermany
Study dates
1 Sep 2024to 1 Sep 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients for tricuspidal clipping without an exclusion criterium

Who may be able to join

  • patients planned for tricuspidal clipping

Who cannot join

  • ventilatory of hemodynamic instability
  • fitting of cuirass not possible
  • unavailability of examiner

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Klinikum Karlsburg, Klinik für Anästhesiologie

    Karlsburg, Mecklenburg-Vorpommern, 17495

Other trials in Germany

About this study

Official title: Effects of Negative Pressure Ventilation on Right Ventricular Function in Cardiological Patients With Reduced Right Ventricular Function.

Patients receives induction of general anesthesia for interventional tricuspidal clipping and standard monitoring for this procedure including arterial and central venous line and transesophageal ultrasound. A cuirass for extrathoracal negative pressure ventilation is placed onto the chest but not switched on. During usual positive pressure ventilation a ventilatory, a hemodynamic and a 3D full volume ultrasounddataset of the right and left ventricle is recorded and severity of tricuspidal regurgitation examined. Afterwards negative pressure ventilation is started and positive pressure ventilation reduced as far as possible without reduction of tidal volumes. The same dataset of ventilation, hemodynamics and ultrasound is collected again during negative pressure ventilation. Afterwards the cuirass gets removed, study finished and everything proceeds as during standard procedure.

Being tested
Negative Pressure Ventilation
Medical subject headings
Ventricular Dysfunction, Right, Heart Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Negative Pressure VentilationDevice

    Substitution of positive pressure ventilation by negative pressure ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. stroke volume index

    transesophageal ultrasound measurement

    Measured: 1 minute

Secondary outcomes (20)
  1. RVEF

    transesophageal ultrasound measurement

    Measured: 1 minute

  2. LVEF

    transesophageal ultrasound measurement

    Measured: 1 minute

  3. volumes of chambers

    transesophageal ultrasound measurement

    Measured: 1 minute

  4. strain

    transesophageal ultrasound measurement

    Measured: 1 minute

  5. VC

    transesophageal ultrasound measurement

    Measured: 1 minute

  6. PISA

    transesophageal ultrasound measurement

    Measured: 1 minute

  7. EROA

    transesophageal ultrasound measurement

    Measured: 1 minute

  8. area of regurgitation of tricuspid valve

    transesophageal ultrasound measurement

    Measured: 1 minute

  9. arterial blood pressures

    hemodynamic measurements

    Measured: 1 minute

  10. venous blood pressures

    hemodynamic measurements

    Measured: 1 minute

  11. pulmonal blood pressures

    hemodynamic measurements

    Measured: 1 minute

  12. heart frequency

    hemodynamic measurements

    Measured: 1 minute

  13. tidal volume

    ventilatory measurements

    Measured: 1 minute

  14. minute volume

    ventilatory measurements

    Measured: 1 minute

  15. breathing rate

    ventilatory measurements

    Measured: 1 minute

  16. etCO2

    ventilatory measurements

    Measured: 1 minute

  17. pO2 in the blood

    blood gases

    Measured: 1 minute

  18. pCO2 in the blood

    blood gases

    Measured: 1 minute

  19. Laktat

    blood gases

    Measured: 1 minute

  20. cerebral oximetry

    NIRS

    Measured: 1 minute

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2024
  2. Study start1 Sep 2024 (estimated)
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion1 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06572072
Sponsor's protocol ID
KAIKB-2024_1
Status last verified
Aug 2024
First submitted
7 Aug 2024
Last updated
26 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Negative Pressure Ventilation and Right Ventricular Dysfunction, run by Karlsburg Hospital at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

stroke volume index (time frame: 1 minute). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in